Safety of Tocilizumab in COVID-19 Patients and Benefit of Single-Dose: The Largest Retrospective Observational Study.
Pharmaceutics
; 14(3)2022 Mar 11.
Article
in En
| MEDLINE
| ID: mdl-35335998
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Pharmaceutics
Year:
2022
Document type:
Article
Affiliation country:
Arabia Saudita
Country of publication:
Suiza